| (Check one): ¨ Form 10-KSB ¨ Form 11-K ¨ Form 20-F x Form 10-QSB ¨ Form N-SAR |
SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549
FORM 12b-25
Commission File Number 0-28931
NOTIFICATION OF LATE FILING |
| For Period Ended: June 30, 2004 | ||
| ¨ Transition Report on Form 10-KSB | ||
| ¨ Transition Report on Form 20-F | ||
| ¨ Transition Report on Form 11-K | ||
| ¨ Transition Report on Form 10-QSB | ||
| ¨ Transition Report on Form N-SAR | ||
| For the Transition Period Ended: | ||
Read Attached Instruction Sheet Before Preparing Form. Please Print or Type.
Nothing in this Form shall be construed to imply that the Commission has verified any information contained herein.
If the notification relates to a portion of the filing checked above, identify the item(s) to which the notification relates:
_______________________________________________________________________________________
PART I REGISTRANT INFORMATION
BioDelivery Sciences International, Inc.
Full name of registrant
_____________________________________________________________________________________________
Former name if applicable:
185 South Orange Avenue, Administrative Building 4
Address of principal executive office (Street and Number)
Newark, New Jersey 07103
City, state and zip code
PART II RULE 12b-25(b) AND (c)
If the subject report could not be filed without unreasonable effort or expense and the registrant seeks relief pursuant to Rule 12b-25(b), the following should be completed. (Check appropriate box.)
| x |
(a) | The reasons described in reasonable detail in Part III of this Form could not be eliminated without unreasonable effort or expense; | ||
| (b) | The subject annual report, semi-annual report, transition report on Form 10-K, 10-KSB, 20-F, 11-K or Form N-SAR, or portion thereof will be filed on or before the 15th calendar day following the prescribed due date; or the subject quarterly report of transition report on Form 10-Q, 10-QSB, or portion thereof will be filed on or before the fifth calendar day following the prescribed due date; and | |||
| (c) | The accountant’s statement or other exhibit required by Rule 12b-25(c) has been attached if applicable. |
2
PART III NARRATIVE
State below in reasonable detail the reasons why Forms 10-K, 10-KSB, 11-K, 20-F, 10-Q, 10-QSB, N-SAR or the transition report portion thereof could not be filed within the prescribed time period.
The Form 10-QSB could not be filed within the prescribed period due to the delays in compiling the information required for the financial statements.
PART IV OTHER INFORMATION
| (1) | Name and telephone number of person to contact in regard to this notification. |
| James A. McNulty (Name) |
(813) (Area Code) |
864-2562 (Telephone Number) |
| (2) | Have all other periodic reports required under Section 13 or 15(d) of the Securities Exchange Act of 1934 or Section 30 of the Investment Company Act of 1940 during the preceding 12 months or for such shorter period that the registrant was required to file such report(s) been filed? If the answer is no, identify report(s). x Yes ¨ No |
| (3) | Is it anticipated that any significant change in results of operations from the corresponding period for the last fiscal year will be reflected by the earnings statements to be included in the subject report or portion thereof? ¨ Yes x No |
If so: attach an explanation of the anticipated change, both narratively and quantitatively, and, if appropriate, state the reasons why a reasonable estimate of the results cannot be made.
3
BioDelivery Sciences International, Inc.
(Name of Registrant as Specified in Charter)
Has caused this notification to be signed on its behalf by the undersigned thereunto duly authorized.
| Date: August 12, 2004 |
By: |
/s/ James A. McNulty | ||||||
4